Company Profile

Celdara Medical LLC
Profile last edited on: 9/21/2022      CAGE: 58S17      UEI: MMVKQXZUBMQ7

Business Identifier: Preclinical therapeutic and diagnostic development programs and services
Year Founded
2008
First Award
2009
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

16 Cavendish Court
Lebanon, NH 03766
   (617) 320-8521
   info@celdaramedical.com
   www.celdaramedical.com
Location: Single
Congr. District: 02
County: Grafton

Public Profile

With strong ties to Dartmouth College and relevant areas of industry, Celdara Medical builds academic and early-stage innovations into high-potential medical companies, identifying discoveries of exceptional value at the earliest stages and moving them toward the market. The firm partners with inventors and their institutions, providing the developmental, financial, and business acumen required to bridge discovery to profitability. With robust funding options, a diverse and high impact Programmatic pipeline, partnerships with world-class academic institutions and industry leaders, Celdara Medical navigates all aspects of a complex industry, accelerating science to improve human health. Examples of programs: scleroderma diagnostics; cellular therapy for cancer; anti-inflammatory therapy; myocardial infarction therapy; atherosclerosis therapy. In January 2015 Cardio3 BioSciences SA (cell therapies) acquired OnCyte LLC (immuno-oncology) from Celdara Medical LLC for $182mm including earn-outs.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
20-24
Revenue Range
2M-2.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Key People / Management

  Jake Reder -- Director, & Chief Executive Officer

  Eric Achtmann -- Director

  Jason W Botten

  Julie H Coleman -- Project Lead

  Colleen D Cooper

  Ebo Derk De Muinck

  Michael W Fanger -- Cofounder, Chairman, & Chief Scientific Officer

  Paul Guyre -- VP Research and Discovery

  Karen Hermanson -- Director of Operations

  Brandy L Houser -- Director and New York Site Head

  Irena Ivanovska

  Charlotte McCleery -- Research Technician

  Joana M Murad -- Senior Director of R&D

  Yolanda Nesbeth -- Director and Washington DC Site Head

  Zachary Parker -- Scientist

  Jake Reder

  Andre Santos -- Administrative Assistant

  Adam Schmucker -- Scientist

  Carin Marie-Louise Sentman